HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aimed at saving lives after stem cell transplants
Disease control Not yet recruitingThis study tests a drug called iptacopan in 30 people who have a serious blood vessel problem after a stem cell transplant. The drug aims to block a part of the immune system that damages blood vessels. Researchers will check if it helps patients live longer and recover organ fun…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Prepping the body before transplant: new study tests exercise program to boost recovery
Disease control Not yet recruitingThis study tests whether a personalized program of exercise, education, and support before a stem cell transplant can improve strength, reduce frailty, and enhance quality of life in adults with blood cancer. About 68 participants will be randomly assigned to either the prehabili…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: Hospital del Salvador • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC